The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer (SCLC) whose disease did not progress after concurrent platinum-based chemotherapy and radiation therapy.

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research. This optimism comes in the wake of the Food and Drug Administration’s (FDA’s) approval of Imdelltra (tarlatamab-dlle) in May 2024 for the treatment of patients with extensive-stage small cell lung cancer (SCLC).

The Queen’s Advanced Lung Institute will feature a team of expert health care providers focused on providing high quality care and early diagnosis of lung cancer for patients.

Discover protective tips to lower lung cancer risk even with a smoking history. Proven approaches for current and former smokers to strengthen lung health.

University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung cancer and better monitoring of treatment.

Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more recent diagnosis and prior glucocorticoid/steroid use.

The Republican House majority is in jeopardy due to the upcoming Supreme Court race in Wisconsin, which could result in a liberal majority on the court and the potential striking down of the state’s congressional map, costing Republicans two U.S. House seats.

The randomized NLST had shown that three rounds of annual screening with low-dose CT reduced lung cancer mortality by 20% among current and former smokers as compared with the same number of annual screens with chest radiography. However, there were risks as well: false positives, complications in procedures for benign nodules, and more.

Thousands of patients with lung cancer face delays in genomic testing, preventing timely access to targeted treatments that could improve survival rates, according to a report.

As technology advances in the fight against cancer, Allegheny Health Network is using a new robotic tool to diagnose lung cancer. For many people doctor's visits bring anxiety, but the word cancer brings a whole new level of stress.

Deborah Stahlnecker, DO, who specializes in pulmonology and critical care medicine, talks about innovative ways St. Luke’s diagnoses and treats patients with asthma, COPD and lung cancer on this Commu